Thymectomy and Thymic Disease

The thymus gland is a small organ located in the upper portion of the chest, behind the breastbone and in front of the heart. It plays an important role in the development of the immune system, particularly during childhood, by helping specialized white blood cells called T lymphocytes mature. The thymus gradually decreases in size and activity after puberty, although thymic tissue may remain present throughout adulthood.

Although many disorders of the thymus are uncommon, several important disease processes can affect this gland. These include thymoma and other thymic tumors, thymic cysts, and autoimmune disorders such as myasthenia gravis. Some thymic abnormalities are discovered incidentally on imaging, while others may cause symptoms because of their size, location, or effects on surrounding structures.

At the Institute for Thoracic Surgery in Miami, Florida, Mark R. Dylewski, M.D., specializes in the surgical evaluation and treatment of conditions involving the thymus. When removal of the thymus is appropriate, a procedure known as a thymectomy may be performed using an advanced minimally invasive approach, including robotic-assisted thoracic surgery, when technically and clinically appropriate.

What Is a Thymectomy?

A thymectomy is the surgical removal of the thymus gland. The procedure may be recommended for patients with a thymic tumor or, in selected patients, as part of the treatment of myasthenia gravis, an autoimmune disorder that affects communication between nerves and muscles.

For patients with thymoma or another thymic tumor, surgery may involve removal of the thymus and surrounding tissue as necessary to achieve complete resection. The extent of surgery depends on the size and location of the tumor and whether it involves nearby structures.

For patients with myasthenia gravis, thymectomy may be considered as part of a comprehensive treatment plan developed in collaboration with neurology and other specialists. The potential role of surgery depends on the patient's age, disease characteristics, presence or absence of a thymoma, and other clinical factors.

Surgical Treatment of Thymic Tumors

Thymoma is the most common tumor arising from the thymus. Although thymomas can behave differently from one another, surgical removal is an important component of treatment when the tumor can be safely and completely resected.

Other, less common thymic tumors can also occur. Evaluation generally includes appropriate chest imaging and, when indicated, tissue diagnosis and staging. Depending on the type and extent of disease, treatment may involve surgery alone or a combination of surgery with chemotherapy and/or radiation therapy.

The goal of surgery is to achieve an appropriate and complete removal of the tumor while protecting the major structures located near the thymus, including the heart, great blood vessels, lungs, and phrenic nerves.

Minimally Invasive Thymectomy

When appropriate, thymectomy can be performed using minimally invasive techniques such as video-assisted thoracoscopic surgery (VATS) or robotic-assisted thoracic surgery. Robotic surgery provides three-dimensional visualization and articulated instruments that can facilitate precise dissection within the confined space of the mediastinum.

The appropriate surgical approach depends on the patient's anatomy, the size and location of the thymic abnormality, the presence of a tumor, and whether surrounding structures are involved. In more complex cases, an open surgical approach may be necessary to achieve complete and safe treatment.

At the Institute for Thoracic Surgery, the objective is to use the least invasive approach that can safely accomplish the required operation without compromising the completeness of treatment.

Thymectomy and Advanced Thymic Surgery

The thymus gland is a small organ located in the front of the chest, behind the breastbone and above the heart. It plays an important role in the development and regulation of the immune system, particularly during childhood, by contributing to the maturation of T lymphocytes. The thymus gradually becomes smaller and less active after puberty, although thymic tissue remains in many adults.

Although diseases of the thymus are relatively uncommon, they can include thymomas, thymic carcinomas, thymic cysts, and other mediastinal abnormalities. The thymus also has an important relationship with certain autoimmune disorders, most notably myasthenia gravis.

At the Institute for Thoracic Surgery in Miami, Florida, Mark R. Dylewski, M.D., provides specialized surgical care for patients with thymic tumors and other conditions involving the mediastinum. When removal of the thymus is indicated, a thymectomy can often be performed using an advanced minimally invasive approach, including VATS or robotic-assisted surgery.

The appropriate operation and surgical approach depend on the underlying diagnosis, the size and location of the abnormality, its relationship to surrounding structures, and the patient's overall health.

Diseases of the Thymus

Several different disease processes can involve the thymus. The most important surgical conditions include thymic epithelial tumors and selected autoimmune disorders.

Thymoma

A thymoma is a tumor arising from the epithelial cells of the thymus. Thymomas generally have a slower growth pattern than thymic carcinomas and are less likely to spread extensively, although they can invade surrounding tissues and can recur after treatment.

Thymomas are also strongly associated with autoimmune disorders. Myasthenia gravis is the most common autoimmune condition associated with thymoma, and a substantial proportion of patients with thymoma have myasthenia gravis.

When a thymoma is localized and can be completely removed, surgical resection is an important component of treatment. Depending on the stage and characteristics of the tumor, radiation therapy and chemotherapy may also be incorporated into treatment.

Thymic Carcinoma

Thymic carcinoma is a different and generally more aggressive type of thymic epithelial tumor. Unlike thymoma, the malignant cells of thymic carcinoma do not resemble normal thymic tissue and are more likely to invade surrounding structures or spread to other parts of the body.

Because thymic carcinoma tends to behave more aggressively than thymoma, treatment often requires a multidisciplinary approach. When the tumor is completely resectable, surgery may be performed with the goal of removing all visible disease, sometimes together with adjacent structures involved by the tumor. Depending on the stage and surgical findings, postoperative radiation and/or chemotherapy may be recommended.

For tumors that are locally advanced or cannot initially be removed completely, treatment may begin with chemotherapy and/or radiation therapy to reduce the extent of disease and potentially make surgical resection possible. Patients with metastatic or unresectable disease may require systemic treatment rather than surgery as the primary treatment.

Thymectomy for Myasthenia Gravis

Myasthenia gravis is an autoimmune disorder in which antibodies interfere with communication between nerves and muscles, resulting in fluctuating muscle weakness. Symptoms can include drooping eyelids, double vision, difficulty swallowing or speaking, and weakness involving the arms, legs, or respiratory muscles.

The thymus has an important relationship with myasthenia gravis, although the exact mechanisms are complex. Some patients with myasthenia gravis have a thymoma, while others have an enlarged or otherwise abnormal thymus without a tumor.

A thymectomy may play an important role in the treatment of selected patients with myasthenia gravis. The decision is individualized and is generally made in collaboration with a neurologist and the patient's broader care team.

For patients with a thymoma, removal of the thymus is generally an essential component of treatment because the tumor itself needs to be addressed. In patients without a thymoma, thymectomy may also be considered for appropriately selected individuals with generalized acetylcholine-receptor-antibody-positive myasthenia gravis, based on factors such as age, disease severity, response to medical treatment, and overall health. International consensus guidance supports thymectomy in selected patients with generalized AChR-antibody-positive myasthenia gravis.

Thymectomy should therefore not be viewed as a treatment that is appropriate for every patient with myasthenia gravis. The potential benefits, timing of surgery, and medical management of the disease should be carefully coordinated with neurology.

What Is a Thymectomy?

A thymectomy is the surgical removal of the thymus gland. For patients with thymoma or another thymic tumor, the operation may involve removal of the tumor together with the surrounding thymic tissue and, when necessary, adjacent tissue involved by the tumor.

For patients with myasthenia gravis, the objective is to remove the thymus and thymic tissue as part of the overall management of the autoimmune disease.

The extent of surgery depends on the underlying condition. A small, localized thymic abnormality may be treated differently from a tumor that extends into surrounding structures.

Surgical Approaches to Thymectomy

Thymectomy can be performed through several different approaches. The choice is based on the disease being treated, tumor size and location, involvement of nearby structures, prior surgery, and the surgeon's ability to safely and completely accomplish the operation.

Open Thymectomy

An open thymectomy provides direct access to the mediastinum through a larger incision. Depending on the specific circumstances, this may involve a median sternotomy or another open approach.

Open surgery remains an important option for large or invasive thymic tumors, particularly when the tumor involves major blood vessels, the heart, pericardium, lung, or other adjacent structures and extensive resection or reconstruction may be required.

The primary advantage of an open approach is broad exposure of the mediastinum and surrounding anatomy. However, it generally involves greater chest-wall disruption and may result in more postoperative discomfort and a longer recovery than minimally invasive approaches.

Video-Assisted Thoracoscopic Surgery (VATS)

Video-assisted thoracoscopic surgery, or VATS, is a minimally invasive technique performed through several small incisions in the chest.

A thoracoscopic camera provides magnified visualization of the mediastinum, while specialized instruments are introduced through the other incisions. VATS can allow removal of the thymus while avoiding the larger incision required for traditional open surgery.

For appropriately selected patients, minimally invasive thymectomy may result in less chest-wall disruption, less postoperative discomfort, and a shorter recovery compared with open surgery.

Multi-Port Robotic Thymectomy

Robotic-assisted surgery represents a further evolution of minimally invasive thoracic surgery. In a multi-port robotic thymectomy, several small incisions are used to introduce the camera and robotic instruments.

The surgeon operates from a console and controls the instruments directly. The robotic platform provides high-definition, three-dimensional visualization and articulated instruments that can facilitate precise dissection within the mediastinum.

This can be particularly useful when the surgeon needs to dissect around delicate structures such as the phrenic nerves, heart, pericardium, and major blood vessels.

Single-Port Robotic Thymectomy

A single-port robotic thymectomy uses a different minimally invasive access strategy. Rather than placing several separate robotic ports, the camera and articulating instruments are introduced through a single primary incision.

The instruments are designed to articulate within the chest despite entering through the same access point. This approach can provide the benefits of robotic visualization and instrument articulation while limiting the number of chest-wall access sites.

Single-port surgery may be appropriate for selected patients with thymic disease, particularly when the anatomy and extent of disease can be safely addressed through a single access point. It is not appropriate for every thymic tumor or every patient.

Multi-Port vs. Single-Port Robotic Surgery

The difference between multi-port and single-port robotic surgery is primarily the method of access to the chest.

With multi-port robotic surgery, the camera and instruments enter through several small incisions, providing multiple access points and considerable flexibility during complex dissection.

With single-port robotic surgery, the instruments and camera are introduced through one primary incision. This can reduce the number of access sites while maintaining three-dimensional visualization and articulated instrumentation.

Neither approach is universally appropriate. The important consideration is whether the selected technique allows the surgeon to safely and completely accomplish the required operation.

Choosing the Right Surgical Approach

The surgical approach should be determined by the disease being treated rather than by the technology itself.

A small, localized thymoma may be amenable to a minimally invasive VATS or robotic thymectomy. A larger tumor or one involving surrounding structures may require a more extensive operation. Similarly, patients undergoing thymectomy for myasthenia gravis may have different surgical considerations than patients undergoing removal of an invasive thymic carcinoma.

When minimally invasive surgery is appropriate, Dr. Dylewski may use VATS, multi-port robotic surgery, or single-port robotic surgery depending on the patient's anatomy and the requirements of the operation.

The objective is to use the least invasive approach capable of safely and completely achieving the necessary treatment, without compromising tumor removal or the patient's safety.

Multidisciplinary Treatment of Thymic Cancer

Treatment of thymic cancer frequently extends beyond surgery. The appropriate strategy depends on whether the tumor is a thymoma or thymic carcinoma, its stage, whether it has invaded surrounding structures, and whether complete surgical resection is possible.

For early-stage, resectable thymoma, surgery is often the primary treatment. More advanced thymoma may require chemotherapy before surgery and radiation therapy following surgery.

For resectable thymic carcinoma, treatment commonly involves surgical resection followed by consideration of radiation therapy, with chemotherapy incorporated when appropriate. Locally advanced or unresectable tumors may require chemotherapy and/or radiation therapy, with surgery reconsidered if the disease becomes resectable.

Because these tumors are uncommon and can involve structures throughout the mediastinum, treatment is best planned through close coordination among thoracic surgery, medical oncology, radiation oncology, radiology, pathology, and other specialists as appropriate.

Advanced Thymic Surgery in Miami

Conditions involving the thymus require careful diagnosis and individualized treatment planning. Whether the patient has a thymoma, thymic carcinoma, another thymic abnormality, or myasthenia gravis in which thymectomy is being considered, the appropriate surgical strategy depends on the specific clinical circumstances.

At the Institute for Thoracic Surgery in Miami, Florida, Mark R. Dylewski, M.D., provides specialized surgical evaluation and treatment of thymic disease. When appropriate, he utilizes advanced minimally invasive techniques, including VATS, multi-port robotic surgery, and single-port robotic surgery, while maintaining open surgery as an important option for complex or invasive disease.

The goal is to provide complete and appropriate treatment while minimizing surgical trauma whenever safely possible.

If you have been diagnosed with a thymic mass, thymoma, thymic carcinoma, or another mediastinal abnormality, or if your neurologist has recommended that you consider thymectomy for myasthenia gravis, a consultation with a specialized thoracic surgeon can help determine whether surgery is appropriate and which approach best fits your individual condition.